Commentary on: Interventions for Bullous Pemphigoid Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP Cochrane Database Syst Rev. 2010 Oct 6;(10):CD002292
Background: Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Oral steroids are the standard treatment. This is an update of the review published in 2005.
Objectives: To assess treatments for bullous pemphigoid.
Garc ía-Romero MT, Werth VP. Randomized Controlled Trials Needed for Bullous Pemphigoid Interventions. Arch Dermatol. 2012;148(2):243-246. doi:10.1001/archdermatol.2011.826